1)厚生労働省難治性疾患政策研究事業血液凝固異常症等に関する研究班「ITP治療の参照ガイド」作成委員会,柏木浩和,桑名正隆,他:成人特発性血小板減少性紫斑病治療の参照ガイド 2019改訂版.臨血 60:877-896,2019
2)Rodeghiero F, Stasi R, Gernsheimer T, et al:Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386-2393,2009
3)蔵本惇:特発性血小板減少性紫斑病分科会報告.厚生省特定疾患特発性造血障害調査研究班研究業績報告書 平成2年度,厚生省特定疾患特発性造血障害調査研究班,p59,1991
4)George JN, Woolf SH, Raskob GE, et al:Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40,1996
5)Kuwana M, Okazaki Y, Kaburaki J, et al:Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia. Am J Med 114:322-325,2003
6)Nishikawa Y, Nishida S, Kuroda K, et al:Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma. Diagnostics (Basel) 12:313,2022
7)Kuwana M, Kurata Y, Fujimura K, et al:Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study. J Thromb Haemost 4:1936-1943,2006